LH logo

Labcorp Holdings Inc. Stock Price

NYSE:LH Community·US$23.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

LH Share Price Performance

US$279.49
52.11 (22.92%)
5.6% undervalued intrinsic discount
US$296.18
Fair Value
US$279.49
52.11 (22.92%)
5.6% undervalued intrinsic discount
US$296.18
Fair Value
Price US$279.49
AnalystConsensusTarget US$296.18

LH Community Narratives

AnalystConsensusTarget·
Fair Value US$296.18 5.6% undervalued intrinsic discount

AI And Collaborations Will Transform Diagnostic Testing

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$296.18
5.6% undervalued intrinsic discount
Revenue growth
5.13% p.a.
Profit Margin
8.24%
Future PE
22.62x
Share price in 2028
US$358.33

Snowflake Analysis

Proven track record with adequate balance sheet.

1 Risk
3 Rewards

Labcorp Holdings Inc. Key Details

US$13.5b

Revenue

US$9.7b

Cost of Revenue

US$3.8b

Gross Profit

US$3.0b

Other Expenses

US$763.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 28, 2025
9.19
28.14%
5.66%
66.4%
View Full Analysis

About LH

Founded
1995
Employees
65450
CEO
Adam Schechter
WebsiteView website
www.labcorp.com

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Recent LH News & Updates

Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Oct 12
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Recent updates

No updates